Hameln Pharma Ltd
01034697
Healthy
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/12/2024
full
Next accounts due
30/09/2026
Confirmation statement
Last: 13/05/2025
Due 27/05/2026
Industry
Officers
Beate Kueter
director · Since 01/04/2022
German
Stephen Allen Watkin
director · Since 28/09/2022
British
Former
David Murray Chisholm
secretary · Resigned 31/12/1997
Drummond Romary Forbes
secretary · Resigned 07/05/2002
Christoph Kerstein
secretary · Resigned 03/02/2003
Susan Margaret Sefton
secretary · Resigned 21/04/1993
Stephen Allen Watkin
secretary · Resigned 31/03/2022
David Murray Chisholm
director · Resigned 31/12/1997
Drummond Romary Forbes
director · Resigned 07/05/2002
Christoph Kerstein
director · Resigned 28/09/2022
Eike Kerstein
director · Resigned 30/09/2003
Stephen Allen Watkin
director · Resigned 31/03/2022
CompanyRankvs 105+ SIC 46460 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 31/12/2024
Turnover
£27.4M
Annual revenue
Net Worth
£10.9M
Balance sheet strength
Cash
£2.7M
Cash in the bank
Profit Before Tax
£4.2M
Bottom line earnings
Net Current Assets
£10.9M
Working capital
Current Assets
£15.5M
Current Liabilities
£4.6M
Fixed Assets
£63k
Debtors
£4.8M
Cost of Sales
£15.6M
Gross Profit
£11.9M
Admin Expenses
£6.3M
Operating Profit
£4.2M
Profit After Tax
£2.9M
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 3.37 | -£679k |
| 2023 | 4.51 | — |
Derived from filed accounts. Not audited figures.